A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study

Clinical trial NCT05394714 · RECRUITING

Trial details

NCT number: NCT05394714
Sponsor: Medigen Biotechnology Corporation
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colon Cancer Stage I

Start date: 2022-03-10
Primary completion: 2028-06-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.